FDA to Reverse 2023 Peptide Ban: What You Need to Know

Washington DC -- In a rare move that overrides previous regulatory decisions, the federal government is moving to restore legal access to 14 popular peptides that were restricted by the Food and Drug Administration (FDA) in late 2023.The shift, recently confirmed by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., marks a significant turning point for patients in Western North Carolina who utilize these compounds for recovery, immune support, and metabolic health.The 2023 "Ban":